CAS 1033699-22-7

Formula: C29H41F2N5O

InChI: InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1/i1D3,2D3

InChI key: GSNHKUDZZFZSJB-ICIYIAOWSA-N

SMILES: [2H]C([2H])([2H])C(C1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C)C([2H])([2H])[2H]

Maraviroc-d6

CAS: 1033699-22-7

Formula: C₂₉H₃₅D₆F₂N₅O

Color and Shape: White To Off-White Solid

Molecular weight: 519.71

Ref: 4Z-M-582

Maraviroc-D6

CAS: 1033699-22-7

Maraviroc-D6 is the deuterated form of Maraviroc (T6016). Maraviroc ( T6016) (UK-427857) acts as a selective CCR5 antagonist and exhibits inhibitory activity against HIV.

Formula: C₂₉H₄₁F₂N₅O

Molecular weight: 519.7

Ref: TM-TMID-0791

Maraviroc-d6

Controlled Product

CAS: 1033699-22-7

Applications Potent, non-competitive CCR5 receptor antagonist; inhibits binding of HIV viral coat protein gp120. Antiviral.
References Fumero, E., et al.: Clin. Microbiol. Infect., 9, 1077 (2003), Walker, D.K., et al.: Drug Metab. Dispos., 33, 587 (2005), Wood, A., et al.: Prog. Med. Chem., 43, 239 (2005),

Formula: C₂₉D₆H₃₅F₂N₅O

Color and Shape: Neat

Molecular weight: 519.7

Ref: TR-M193002

Maraviroc-[d6]

CAS: 1033699-22-7

Formula: C₂₉H₄₁F₂N₅O

Molecular weight: 519.7

Ref: BE-MD-7312

Maraviroc-d6

CAS: 1033699-22-7

Maraviroc-d6 is a medicinal compound that has been developed as an inhibitor of kinases, which are enzymes involved in cell cycle regulation and apoptosis. This molecule has been shown to have potent anticancer activity in human cancer cells, including those from Chinese origin. Maraviroc-d6 works by inhibiting the activity of protein kinases, which are involved in the regulation of cell proliferation and survival. This inhibition leads to the induction of apoptosis, or programmed cell death, in cancer cells. Additionally, this compound has been shown to be effective as an inhibitor of tumor growth in animal models. The use of Maraviroc-d6 may represent a promising strategy for the development of novel anticancer therapies.

Formula: C₂₉H₄₁F₂N₅O

Purity: Min. 95%

Molecular weight: 519.7 g/mol

Ref: 3D-IRB69922